XML 58 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Stock Options Awards and Restricted Stock Grants (Details) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average exercise price, granted $ 2.03 $ 4.16
Share-Based Payment Arrangement, Option [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options outstanding, beginning balance 760,220  
Weighted average exercise price, beginning balance $ 4.55  
Options outstanding, granted 335,000  
Weighted average exercise price, granted $ 1.32  
Options outstanding, vested and issued  
Weighted average exercise price, vested and issued  
Options outstanding, Terminated (125,672)  
Weighted average exercise price, Terminated $ 8.99  
Options outstanding, ending balance 969,548  
Weighted average exercise price, ending balance $ 2.86  
Weighted average contractual terms 8 years 10 months 24 days  
Options outstanding, aggregate intrinsic value  
Options outstanding, exercisable 400,879  
Weighted average exercise price, exercisable $ 4.03  
Weighted average contractual terms, exercisable 8 years 8 months 12 days  
Options outstanding, aggregate intrinsic value, exercisable  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Non-vested stock awards, beginning balance 69,650  
Weighted average grant date fair value, beginning balance $ 1.92  
Non-vested stock awards, granted 2,100  
Weighted average grant date fair value, granted $ 1.30  
Non-vested stock awards, vested and issued (53,200)  
Weighted average grant date fair value, vested and issued $ 1.96  
Non-vested stock awards, Terminated (200)  
Weighted average grant date fair value, Terminated $ 4.60  
Non-vested stock awards, ending balance 18,350  
Weighted average grant date fair value, ending balance $ 1.70  
Non-vested stock awards, aggregate intrinsic value